Genetic differences in breast tumors; how PBMs push up prices of specialty generics

New research shows Black patients are more likely to have tumors with mutations associated with treatment resistance.

March 31, 2023 Check out STAT+

Sponsored By

Adobe Genetic differences in breast tumors may contribute to racial disparities Social factors like access had been linked to worse results for Black patients. A study suggests biological differences may also play a role. By Angus Chen STAT+ | Drug middlemen switch tactics, but the outcome is the same: high prices Prescription drug middlemen are shifting from rebates to increasingly larger administrative fees and specialty-generic markups. By John Wilkerson STAT+ | Dutch health minister won't cover a Gilead cancer drug due to the cost "Inefficient spending means less money is available for other important areas of care," said Dutch health minister Ernst Kuipers. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser